Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The annual call for changes in UK national screening programs was rescheduled

In August 2023, the UK National Screening Committee (UK NSC) announced that the annual call for new topics is rescheduled and will be open from July 1 to September 30. 

Previously, the annual call for new topics ran from September 1 to December 31 (the last one ran in 2022). Thus, the next call will open on July 1, 2024, and there will be no annual call in 2023

During the open call, individuals or organizations can propose potential new screening programs, new technologies not yet considered by the UK NSC, modifications to current screening programs, or early updates (following new evidence) of programs reviewed regularly.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.